elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36852277-0C610EA3-DAC9-40FC-ADF9-0F3A81C240C5
Q36852277-0C610EA3-DAC9-40FC-ADF9-0F3A81C240C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36852277-0C610EA3-DAC9-40FC-ADF9-0F3A81C240C5
From bortezomib to other inhibitors of the proteasome and beyond.
P2860
Q36852277-0C610EA3-DAC9-40FC-ADF9-0F3A81C240C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36852277-0C610EA3-DAC9-40FC-ADF9-0F3A81C240C5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
565a9bd90b42e9e43f479f4a838095bf3005787e
P2860
Synthetic and structural studies on syringolin A and B reveal critical determinants of selectivity and potency of proteasome inhibition